Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2C | Q5R387 | 10/20 | 0.62 |
| ▸ | PLA2G2A | P14555 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.37 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6547737 | 0.85 | PLA2G2C (0.62) | PLA2G2CPLA2G2ACA1CA2 | |
| SCHEMBL11506429 | 0.81 | PLA2G2C (0.59) | PLA2G2CPLA2G2ACA1CA2TAS1R3 | |
| SCHEMBL28751562 | 0.80 | PLA2G2C (0.67) | PLA2G2CPLA2G2ACA2 | |
| SCHEMBL2666554 | 0.80 | PLA2G2C (0.67) | PLA2G2CPLA2G2ACA2 | |
| SCHEMBL24124368 | 0.79 | PLA2G2C (0.71) | PLA2G2CPLA2G2ACA1CA2TAS1R3 | |
| SCHEMBL11606057 | 0.77 | PLA2G2C (0.64) | PLA2G2CPLA2G2A | |
| SCHEMBL13715798 | 0.77 | PLA2G2C (0.59) | PLA2G2CPLA2G2ACA1CA2 | |
| SCHEMBL19271824 | 0.77 | PLA2G2C (0.64) | PLA2G2CPLA2G2A | |
| SCHEMBL19271786 | 0.77 | PLA2G2C (0.64) | PLA2G2CPLA2G2A | |
| SCHEMBL6940595 | 0.77 | PLA2G2C (0.64) | PLA2G2CPLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970104-B1 | BICYCLIC ANALGESIC COMPOUNDS | ZENO ROYALTIES & MILESTONES LLC (US) | 2019-04-24 | — | — | EP | disclosed |